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ABSTRACTSConclusions: Our study has shown that patients who present with
thickening or lumpiness of the breast should all have FNAC or core biopsy
of the symptomatic area, even in the presence of normal USS and/or
mammography.
This highlight's the importance of a thorough triple assessment in all
patients presenting to the breast clinic.
0236: IS THE BENEFIT OF INTRAOPERATIVE SENTINEL LYMPH NODE
BIOPSY (SLNB) ANALYSIS USING ONE-STEP NUCLEIC-ACID
AMPLIFICATION (OSNA) NEGATED BY THE NEED FOR FURTHER
BREAST SURGERY?
Dionysios D. Remoundos 1, Hannah A. Wilson 1, Farid Ahmed 1, Yoon
Chia 2, Giles H. Cunnick 1. 1Department of General Surgery, Wycombe
General Hospital, High Wycombe, UK; 2Department of Histopathology,
Wycombe General Hospital, High Wycombe, UK
SLNB is standard practice for axillary staging in clinically node-negative
breast cancer patients. Traditionally, SLNB-positive patients required
delayed axillary lymph node clearance (ALNC). The development of intra-
operative analysismethods, such asOSNA, hasmade single-stage procedures
possible.However, some argue that their beneﬁtmay benegatedby theneed
for further breast surgery. We aimed to assess the beneﬁt of intraoperative
OSNA compared to conventional SLNB analysis and delayed ALNC.
400 consecutive patients with clinically and radiologically normal axillary
lymph nodes, who underwent mastectomy or breast-conserving surgery
for invasive cancer or multifocal DICS, in a single institution fromMay 2010
to November 2011, were included. Routine localisation and intra-operative
OSNA analysis were performed. Patients positive for metastasis proceeded
to ALNC at the same setting. Those requiring additional breast procedures
were identiﬁed.
142 patients underwent an immediate ALNC. 14.6% of patients required re-
excision breast surgery. Only 21.4% of OSNA-positive patients required
further surgery.
Despite the need for re-excision breast surgery in cases of positive
margins, intra-operative OSNA analysis reduces the number of patients
requiring further surgery by 78.6%. Offering a single operation is better for
patients and the health economy, reducing waiting times and expediting
the start of adjuvant treatments.
0306: ULTRASOUND EVALUATION OF BREAST CANCER DEPTH. DOES
THIS PREDICT THE LIKELIHOOD OF SUPERFICIAL MARGIN
INVOLVEMENT?
Lulu Tanno, Catherine Boffa, Gavin Royle, Rachel Oeppen, Ramsey
Cutress. Southampton University Hospital Trust, Southampton, UK
Aim: We determined superﬁcial margin involvement (SMI) in patients
undergoing breast conserving surgery (BCS) and assessed if ultrasound
tumour depth predicts the likelihood of SMI.
Methods: A retrospective review of 201 BCS procedures undertaken in
2009. US report and images were used to determine the superﬁcial depth
of tumours.
Results: Tumour was present at one or more margin (including deep or
superﬁcial) in 41 (20%) cases and led to further surgery in 15 cases. A skin
ellipse was excised in 76 (38%), and of these, no specimens had isolated
SMI. In 2 cases skin involvement was clinically apparent pre-operatively.
From those without skin resection the superﬁcial margin was the only
margin involved in 4 cases. In total there were 2 re-excisions for isolated
superﬁcial margins, one following a skin ellipse and the other following no
skin resection. The mean USS depth of the tumour in cases with SMI was
4mm whilst the mean depth of those without SMI was 10mm (p¼0.002).
Conclusions: Isolated SMI is rare following BCS. US depth may be a good
indicator of SMI. If USS depth is <5mm an ellipse of skin overlying the
cancer should be considered rather than excision from a distant site.
0307: INTRA-OPERATIVE ULTRASOUND IS AN EFFECTIVE TECHNIQUE
FOR EXCISION OF EARLY BREAST CANCER
Jennifer Pollard, S. Pathak, Anu Shrotri, C.D. Parmar, Lee Martin. University
Hospitals Aintree, Liverpool, UK
Introduction: Radio-guided occult lesion localisation (ROLL) has been
used to excise impalpable breast lesions instead of wire-guided local-
isation. We hypothesise Intra-operative Ultrasound Marking (IUM) is aseffective as ROLL for excision of ultrasound-detectable lesions and more
cost-effective.
Methods: Retrospective analysis performed on consecutive patients
undergoing IUM WLE over 3 years. Baseline demographics, tumour size,
margin clearance, histology and further procedures performed were
analysed.
Results: Sixty-six IUM WLE's were performed June 2008-November 2011
for non-palpable lesions, with 100% success rate for excision. Mean patient
age 58-years (27-81 years). Mean radiological tumour size 13.5mm (4.5-
28.4mm), mean invasive tumour size 18.7mm (3-77mm) and mean spec-
imen weight 43.9 grams. 63 patients (95.3%) had clear radial margins
(mean clearance 3.35mm, range 1.1-7mm). Three patients (4.7%) had
positive margins for invasive malignancy. These results compare favour-
ably with ROLL data.
Conclusions: Our results demonstrate no malignant lesions were
missed; therefore this procedure can be safely used to excise early,
impalpable screen-detected breast cancers. It improves peri-operative
patient journey; increases patient safety and convenience, whilst
making savings in cost of nuclear medicine services. Furthermore, it can
be performed in hospitals without a nuclear medicine department. Our
recommendations are breast surgeons will need to undergo training in
ultra-sound scanning.
0318: MEDICAL ASTROLOGY: DEBUNKING THE MYTH FOR BREAST
DISEASE
Thomas Micic, Rachel Barnes, Kelvin Gomez. Aneurin Bevan Health Board
Trust, Abergavenny, South Wales, UK
Introduction: Medical astrology predicts that disease is under the inﬂu-
ence of astrological signs. Being born within the zodiac sign of Cancer is
meant to increase your chances of developing diseases of the breast.
Methods: A retrospective cohort of 1458 patients who presented with
breast disease was derived from hospital admission data from a single
Health Board from January 2008 to February 2011. Statistical conﬁrmation
of the dataset was performed using the Chi-Squared test.
Results: Results showed that the probability of developing benign breast
disease and being born within the zodiac sign of Cancer was 7.83% (Range
6.01-10.97% for the other zodiac signs); pre-invasivemalignancy was 8.76%
(Range 5.84-11.68% for the other zodiac signs); and for malignant disease
was 9.25% (Range 7.71-9.91% for the other zodiac signs). There was no
statistically signiﬁcant difference between the Zodiac groups.
Conclusions: The basis for medical astrology, as with astrology itself, is
rooted in superstition and pseudoscience. Unfortunately, a proportion of
patients presenting with breast disease still seek advice from medical
astrologers, who may inﬂuence their treatment options. Our results show
that there is no statistical difference. The authors hope that by debunking
this myth, fewer patients will be adversely affected by inappropriate
advice.
0345: SAME DAY ADMISSIONS ARE KEY TO SAVING MONEY IN ELECTIVE
BREAST SURGERY
Usman Khalid, Nicola Woodcock, Pawel Pietrzak, Sumit Goyal. The Cardiff
and Vale Breast Centre, Cardiff, Wales, UK
Aim: To evaluate our length of stay for Elective Breast Surgery and explore
ways to increase our rate of Same Day Admissions (SDA's) and reduce
costs.
Method: Retrospective data on admission, discharge and day of surgery
were collected for all patients who underwent Breast Surgery at Cardiff
Breast Centre between April 2010 and March 2011.
Results: 626 patients underwent Breast Surgery, with a median age of
57 and average length of stay 3 days. 28% of patients were admitted on
day of surgery (62% of which day-cases), 71% day before surgery and 1%
more than 1 day before surgery. Reasons for admission day before
surgery were: Sentinel Node Radioisotope(RI) injection(50%), Wire
insertion(6%), ‘Normal Culture' within this trust for pre-operative
assessment(44%).
Conclusions: Based on a £200 cost per bed day, we estimated that our
Trust could save £89,000 per year if all patients arrived on day of surgery.
Ways to increase our SDA rate include: 1. RI injection day before surgery
and admission on day of surgery; 2. Setup of a pre-assessment clinic -
Clinic space, nursing staff and junior doctors are already set in place for this
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ABSTRACTStrust therefore only an additional cost of £10,000 per year would be
required for a dedicated anaesthetist.
0383: ARE THE NUMBER OF LYMPH NODES EXCISED DURING AXILLARY
NODE CLEARANCE SURGERY AFFECTED BY NEOADJUVANT
CHEMOTHERAPY?
David Naumann, Martin Sintler. Sandwell and West Birmingham Hospitals
NHS Trust, West Midlands, UK
Introduction: Neoadjuvant chemotherapy may change the macroscopic
architecture of lymph nodes (LNs) to such a degree that the number
counted by a histologist following axillary node clearance (ANC) is lower
than expected by the surgeon. We test the hypothesis that chemotherapy
prior to ANC reduces the number of LNs.
Methods: Retrospective study examining records for all patients under-
going ANC at a NHS Trust over a 17 month period. We compared the
number of LNs counted on histological examination between the patient
groups who had received neoadjuvant chemotherapy and those who had
not, with further subdivision into groups who had undergone sentinel
node biopsy (SNB) prior to ANC and those who had not.
Results: There were 237 ANC operations including 98 ANC alone, 36 ANC
following chemotherapy but no SNB, 61 ANC following SNB but no
chemotherapy, and 42 following both SNB and chemotherapy, yielding
14.4 (6.5), 13.0 (5.8), 14.3 (5.1), and 15.1 (5.5) mean LNs respectively
(p ¼ 0.398).
Conclusion:We ﬁnd no statistically signiﬁcant difference in the number of
LNs from excised axillary tissues between patients who received neo-
adjuvant chemotherapy and those who had not. Lower than expected
number of LNs may not credibly be attributed to neoadjuvant chemo-
therapy.
0387: BLUE DYE DIRECTED AXILLARY NODE SAMPLING- REVISITING
THE ROLE
Rachel French, Vijay Kurup. University Hospital North Tees, Stockton-on-
Tees, UK
Aim: To evaluate whether combination of Sentinel Lymph Node Bio-
psy(SLNB) using patent blue dye and four node sampling as a reasonable
alternative to SLNB (dual technique), in early breast cancer as guidelines
recommend.
Methods: A retrospective study of SLNB using patent blue dye and four
nodes sampling performed by a single surgeon from 2006-'11. All
245patients treated byWLE were included. SLN were localised by injecting
2 ml patent blue dye in the subareolar with further Level 1 sampling done
to achieve a minimum of 4 nodes, by palpation. Node positive axillae were
treated by radiotherapy or clearance as per MDT decision.
Results: The detection rate was 97.95% (240/245 patients). 41 patients had
axillary metastases- 38 cases SLN positive and 3 Negative. False negative
rate 1.5%, Sensitivity 92.7% and negative predictive value 98.5%. 21/
41patients (51.2%) had only one node involved in their axilla. Axillary
morbidity was minimal and recurrence nil at 5 years.
Conclusion: Injection technique and experience of surgeon can lead up to
98% SLN detection using blue dye alone with comparable false negativity.
Combining with four node sampling reduces the impact of false negativity
and avoids unnecessary axillary clearance in single node disease (51.2%).
0432: TRIPLE NEGATIVE BREAST CANCER; BACKGROUND, TREATMENT
AND FUTURE OPTIONS
Rebecca Watts-Cherry 1, Eleri Davies 2. 1Cardiff University, Cardiff, UK;
2 Llandough Hospital, Cardiff, UK
Aims: Identify a subgroup of patients who were diagnosed with triple
negative breast cancer (TNBC) in Cardiff and Vale (CAV) in 2006-2011, to
enable an understanding of how TNBC patients present, what treatment is
given and which patients had recurrences.
Method: This was a retrospective study. The pathology database gave a list
of TNBC patients. Using this information, the Clinical Portal and CANNISC
databases allowed the proforma to be completed, which was then ana-
lysed. All people diagnosed as having TNBC in CAV in 2006 - 2011 were
included. No age or gender restriction was imposed.
Results: 101 patients were included in the study, of these 77 (76%) are alive
up to 5 years after. 11 (11%) developed recurrences and 7 (7%) developedmetastasis. Of these 86% had grade 3 tumours (study average(sa)¼79%),
86% had invasive ductal carcinoma (sa¼ 87%) and the average size was
54mm (sa¼ 33mm). 67 (66%) patients received chemotherapy which was
found to enhance survival (p¼0.003).
Conclusion: TNBC disease is very responsive to chemotherapy agents, so
must be given to all triple-negative patients as routine treatment irre-
spective to the histological result. The results obtained compare appro-
priately with the majority of studies already conducted.
0438: DIFFERENCES IN PATIENT EXPERIENCE AND UNDERSTANDING OF
CONSENT WHEN CARRIED OUT IN CLINIC AND ON THE DAY OF
SURGERY
Amy Lord, Shehryer Naqvi, Ramesh Babu, Richard Sainsbury. St Mary's
Hospital, Isle of Wight, UK
Aims: To assess patients’ subjective perception of consent and recall of
information when comparing those consented in clinic with those con-
sented immediately before surgery.
Methods: Prospective study of patients undergoing breast and general
surgical operations. Patients were randomised to consent in clinic or
consent immediately before surgery. Patients completed a post-operative
questionnaire assessing satisfaction and recall of complications using
a tick-box list of 16 common complications, 6 of which were correct for
each operation. An overall score of correct minus incorrect answers was
calculated out of 6.
Results: 27 patients were included, 17 consented immediately pre-oper-
atively, and 10 in clinic (mean - 13 days pre-op). The mean overall score for
recollection of complications was 3 when consented on the day and 2.9
when consented in clinic. Subjective ratings of experience were not
signiﬁcantly different between the groups. Overall recall rates were better
for general complications (96% bleeding, 100% infection and 74% anaes-
thetic risk) than speciﬁc risks (25% seroma in breast patients).
Conclusions: In our experience patients can be consented either in clinic
or on the day of operation as there is no difference in their subjective
perceptions or recall of information. However only small numbers have
been assessed so far.
0457: IS MAMMOGRAM AN ESSENTIAL INVESTIGATION FOR DETECTING
BREAST CANCER IN PATIENTS YOUNGER THAN 40 YEARS?
Annabelle Williams, Rachel Hung, Yazan Masannat, Anil Desai, Prakash
Sinha. Princess Royal University Hospital, London, UK
Aims: Breast cancer is the commonest female cancer diagnosed in the UK.
In November 2010, the ‘Best Practice Diagnostic Guidelines for Patients
Presenting with Breast Symptoms' were amended. This study aims to
evaluate the safety of the proposed changes that statemammography is no
longer an essential ﬁrst line investigation for women under the age of 40,
with breast symptoms,
Methods: A retrospective cohort study of 40 patients, from January 2007
to July 2011, with histologically conﬁrmed breast cancer diagnosed when
under the age of 40 was performed by comparing mammography and
ultrasound results.
Results: All patients presented with a symptomatic lump and underwent
ultrasound scanning, mammography and core biopsy. No patient with
a normal ultrasound was found to have an abnormal mammogram. In all
40 patients ultrasound scanning showed 100% sensitivity in identifying the
breast lesions with 95% identiﬁed as indeterminate, suspicious or malig-
nant radiologically.
Conclusions: The new symptomatic breast guidelines are safe to imple-
ment, as ultrasound is an adequate ﬁrst line investigation. If any suspicious
ultrasound abnormality is detected then mammogram is essential for
further assessment as this could demonstrate further pathological changes
which may affect clinical management. This should lead to improved
patient care and resource management.
0471: BREAST PAIN UNDER THE AGE OF 50: IS MAMMOGRAPHY REALLY
NECESSARY?
R.E. Foulkes, R. Thomas, S. Ghosh. Nevill Hall Hospital, Abergavenny, UK
Aim: The aim of this study was to assess whether routine mammography
in patients presenting with painful breasts, and no palpable mass is
necessary in those under the age of 50 years.
